Phathom Pharmaceuticals Inc (PHAT)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
4.41 +0.19 (+4.50%) 03/14/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 4.45 +0.04 (+0.91%) 18:25 ET
for Fri, Mar 14th, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 297,263 | 381,393 | 155,385 | 183,259 | 287,496 |
| Receivables | 38,797 | 1,637 | N/A | N/A | N/A |
| Inventories | 3,208 | 1,208 | N/A | N/A | N/A |
| TOTAL | $360,134 | $397,432 | $160,512 | $186,526 | $291,368 |
| Non-Current Assets | |||||
| PPE Net | 1,476 | 2,146 | 1,207 | 650 | 986 |
| Other Non-Current Assets | 16,708 | 14,264 | 3,091 | 2,255 | 2,757 |
| TOTAL | $18,184 | $16,410 | $4,298 | $2,905 | $3,743 |
| Total Assets | $378,318 | $413,842 | $164,810 | $189,431 | $295,111 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | N/A | 7,353 |
| Accounts payable and accrued liabilities | 10,507 | 12,601 | 9,997 | 5,150 | 16,782 |
| Accrued Expenses | 54,943 | 18,343 | 15,532 | 13,284 | 30,915 |
| Other current liabilities | 19,777 | 7,111 | N/A | N/A | N/A |
| TOTAL | $85,728 | $38,781 | $26,237 | $18,921 | $55,524 |
| Non-Current Liabilities | |||||
| Long Term Debt | 201,409 | 137,842 | 95,264 | 89,671 | 39,634 |
| aiOther Non-Current Liabilities | 344,761 | 309,978 | 118,123 | 8,683 | 5,682 |
| TOTAL | $546,170 | $447,820 | $213,387 | $98,354 | $45,316 |
| Total Liabilities | $631,898 | $486,601 | $239,624 | $117,275 | $100,840 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 69,637 | 58,477 | 41,973 | 31,713 | 31,322 |
| Common Shares | 6 | 5 | 3 | 3 | 3 |
| Retained earnings | -1,263,011 | -928,685 | -727,093 | -529,370 | -385,487 |
| TOTAL | $-253,580 | $-72,759 | $-74,814 | $72,156 | $194,271 |
| Total Liabilities And Equity | $378,318 | $413,842 | $164,810 | $189,431 | $295,111 |